Etienne Meylan

16.1k citations

43 papers · 8.5k indexed · 5 hit papers · h-index 31

Impact in

Immunology top 0.2%
- interferon and immune responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immune cells in cancer
Cancer Research top 0.5%
- NF-κB Signaling Pathways

Papers in

Immunology 27
- interferon and immune responses 13
- Immune Response and Inflammation 11
- Immune cells in cancer 11
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 5
Cancer Research 15
- NF-κB Signaling Pathways 9

Co-authors: Jürg Tschopp Kay Hofmann Joseph Curran Darius Moradpour Michael Karin Marco Binder Ralf Bartenschlager Fabio Martinon
Journals: Cell Reports (3 papers)Nature (3 papers)EMBO Reports (3 papers)EMBO Molecular Medicine (2 papers)Current Biology (2 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

Etienne Meylan

43 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories log scale

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors 2020 · 477 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Immunology
2018 FEBS Journal
2006 Nature
2005 Nature
2004 Nature Immunology

Peers

Countries citing papers authored by Etienne Meylan

Since Specialization

Citations

This map shows the geographic impact of Etienne Meylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etienne Meylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etienne Meylan more than expected).

Fields of papers citing papers by Etienne Meylan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etienne Meylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etienne Meylan. The network helps show where Etienne Meylan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Etienne Meylan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Etienne Meylan Line = papers co-authored together Etienne Meylan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth EMBO Molecular Medicine ·المنذر نور الدائم, Ferdi Çelikay ve Erdal Gümüş, G. Ruiz-Villarverde, Justine Pascual, Amber D. Bowler, Vincent Roh, Nadine Fournier, Ligia Craciun, Pieter Demetter, Freddy Radtke, Etienne Meylan	2023	21
2	GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy Cancer Research ·Pierre‐Benoit Ancey, Caroline Contat, Gaël Boivin, Morotomi Masami, Justine Pascual, Nadine Zangger, Jean Yannis Perentes, Solange Peters, E. Dale Abel, David G. Kirsch, Jeffrey C. Rathmell, Marie‐Catherine Vozenin, Etienne Meylan	2021	123
3	Neutrophil metabolism in the cancer context Seminars in Immunology ·المنذر نور الدائم, Etienne Meylan	2021	32
4	RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung Adenocarcinoma Journal of Thoracic Oncology ·Julien Faget, Caroline Contat, Nadine Zangger, Solange Peters, Etienne Meylan	2017	18
5	Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer Cell Reports ·Julien Faget, Svenja Groeneveld, Gaël Boivin, Martial Sankar, Nadine Zangger, Miguel Garcia, Nicolas Guex, Inti Zlobec, Loïc Steiner, Alessandra Piersigilli, Ioannis Xénarios, Etienne Meylan	2017	160
6	Mutant CTNNB 1 and histological heterogeneity define metabolic subtypes of hepatoblastoma EMBO Molecular Medicine ·Stefania Crippa, Pierre‐Benoit Ancey, Jessica Vázquez, Paolo Angelino, Anne‐Laure Rougemont, Catherine Guettier, Vincent Zoete, Mauro Delorenzi, Olivier Michielin, Etienne Meylan	2017	43
7	GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer DSpace@MIT (Massachusetts Institute of Technology) ·Mark Masin, Jessica Vázquez, Simona Rossi, Svenja Groeneveld, Massita MOHAMAD, Petra Schwalie, Bart Deplancke, Darius Moradpour, Trudy G. Oliver, Etienne Meylan, Rawela Siṅgha, Jérôme Gouttenoire	2014	1
8	GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer Cancer & Metabolism ·Mark Masin, Jessica Vázquez, Simona Rossi, Svenja Groeneveld, Massita MOHAMAD, Petra Schwalie, Bart Deplancke, Rawela Siṅgha, Jérôme Gouttenoire, Darius Moradpour, Trudy G. Oliver, Etienne Meylan	2014	124
9	Regulation of Monocyte Functional Heterogeneity by miR-146a and Relb Cell Reports ·Martin Etzrodt, Virna Cortez‐Retamozo, Andita Newton, Jimmy L. Zhao, Aylwin Ng, Moritz Wildgruber, Pedro Romero, Thomas Würdinger, Ramnik J. Xavier, Frédéric Geissmann, Etienne Meylan, Matthias Nahrendorf, Filip K. Świrski, David Baltimore, Ralph Weissleder, Mikäel J. Pittet	2012	98
10	Response and Resistance to NF-κB Inhibitors in Mouse Models of Lung Adenocarcinoma Cancer Discovery ·Wen Xue, Etienne Meylan, Trudy G. Oliver, David M. Feldser, Monte M. Winslow, Roderick Bronson, Tyler Jacks	2011	109
11	Caspase-2-Mediated Cleavage of Mdm2 Creates a p53-Induced Positive Feedback Loop Molecular Cell ·Trudy G. Oliver, Etienne Meylan, Gregory P. Chang, Wen Xue, James R. Burke, Timothy J. Humpton, Diana Hubbard, Arjun Bhutkar, Tyler Jacks	2011	120
12	Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus Journal of Viral Hepatitis ·Kenichi Morikawa, Christian M. Lange, Jérôme Gouttenoire, Etienne Meylan, Volker Brass, François Pénin, Darius Moradpour	2011	109
13	Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma Nature ·Etienne Meylan, (unknown), David M. Feldser, О. М. Умаров, 秀樹千本, Chensi Ouyang, Tyler Jacks	2009	58
14	Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system† Hepatology ·Pantxika Bellecave, Magdalena Filipowicz Sinnreich, Olivier Donzé, Martín Sánchez-Sanguinetti, Jérôme Gouttenoire, Etienne Meylan, Luigi Terracciano, Jürg Tschopp, Christoph Sarrazin, Thomas Berg, Darius Moradpour, Markus H. Heim	2009	94
15	The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases Cell Death and Differentiation ·Manuele Rebsamen, Etienne Meylan, Joseph Curran, Jürg Tschopp	2008	69
16	Intracellular pattern-recognition receptors☆ Advanced Drug Delivery Reviews ·Catherine Dostert, Etienne Meylan, Jürg Tschopp	2008	42
17	Intracellular pattern recognition receptors in the host response Nature ·Etienne Meylan, Jürg Tschopp, Michael Karin Hit paper breakdown →	2006	916
18	Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus Nature ·Etienne Meylan, Joseph Curran, Kay Hofmann, Darius Moradpour, Marco Binder, Ralf Bartenschlager, Jürg Tschopp Hit paper breakdown →	2005	1968
19	Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome Current Biology ·Fabio Martinon, Laetitia Agostini, Etienne Meylan, Jürg Tschopp	2004	474
20	RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation Nature Immunology ·Etienne Meylan, Kim Burns, Kay Hofmann, Vincent Blancheteau, Fabio Martinon, Michelle A. Kelliher, Jürg Tschopp Hit paper breakdown →	2004	674

About Etienne Meylan

Etienne Meylan is a scholar working on Immunology, Cancer Research, Oncology, Immunology and Allergy and Molecular Biology, having authored 43 papers that have together received 8.5k indexed citations. Recurring topics across this work include interferon and immune responses (13 papers), Immune Response and Inflammation (11 papers), Immune cells in cancer (11 papers), NF-κB Signaling Pathways (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), RNA modifications and cancer (5 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Immunology (5.3k citations), Cancer Research (1.8k citations), Hepatology (695 citations), Molecular Biology (3.7k citations) and Oncology (1.4k citations). Etienne Meylan has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Jürg Tschopp, Kay Hofmann, Joseph Curran, Darius Moradpour, Michael Karin, Marco Binder, Ralf Bartenschlager, Fabio Martinon, Pierre‐Benoit Ancey and Caroline Contat. Their work appears in journals such as Cell Reports, Nature, EMBO Reports, EMBO Molecular Medicine and Current Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact